Recombinant tissue plasminogen activator is a useful alternative to heparin in priming Quinton Permcath

This publication has 19 references indexed in Scilit:

• Streptokinase therapy
  Postgraduate Medicine, 1998
• Predictors of stroke in patients receiving chronic hemodialysis
  Kidney International, 1996
• The bleeding risk in chronic haemodialysis: preventive strategies in high-risk patients
  The Netherlands Journal of Medicine, 1996
• Treatment of Hemodialysis Fistula Pseudoaneurysms with Detachable Balloons: Technique and Preliminary Results
  Journal of Vascular and Interventional Radiology, 1992
• Use of Dacron Cuffed Silicone Catheters as Long-Term Hemodialysis Access
  Asaio Journal, 1992
• Hemodialysis with a Permcath Kept Open with Streptokinase and Later Citrate in a Heparin-Sensitive Patient
  Nephron, 1991
• Investigational Use of Tissue Plasminogen Activator (t‐PA) for Occluded Central Venous Catheters
  Journal of Parenteral and Enteral Nutrition, 1990
• Successful use of double-lumen, silicone rubber catheters for permanent hemodialysis access
  Kidney International, 1989
• Use of Permcath (Quinton) Catheter in Uraemic Patients in Whom the Creation of Conventional Vascular Access for Haemodialysis Is Difficult
  Nephron, 1989
• RANDOMISED CONTROLLED TRIAL OF RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR VERSUS UROKINASE IN THE TREATMENT OF ACUTE PULMONARY EMBOLISM
  The Lancet, 1988